nodes	percent_of_prediction	percent_of_DWPC	metapath
Cidofovir—TYMP—esophageal cancer	0.493	1	CbGaD
Cidofovir—TYMP—Capecitabine—esophageal cancer	0.435	0.971	CbGbCtD
Cidofovir—SLC22A6—Methotrexate—esophageal cancer	0.0131	0.0291	CbGbCtD
Cidofovir—Tenofovir—ABCC2—esophageal cancer	0.000926	1	CrCbGaD
Cidofovir—TYMP—Fluoropyrimidine Activity—XRCC3—esophageal cancer	0.000351	0.183	CbGpPWpGaD
Cidofovir—TYMP—Fluoropyrimidine Activity—CYP2A6—esophageal cancer	0.000204	0.106	CbGpPWpGaD
Cidofovir—Pancytopenia—Cisplatin—esophageal cancer	0.000177	0.00317	CcSEcCtD
Cidofovir—Herpes simplex—Methotrexate—esophageal cancer	0.000177	0.00317	CcSEcCtD
Cidofovir—Haemolytic anaemia—Capecitabine—esophageal cancer	0.000176	0.00316	CcSEcCtD
Cidofovir—Eye pain—Capecitabine—esophageal cancer	0.000176	0.00316	CcSEcCtD
Cidofovir—Renal failure acute—Capecitabine—esophageal cancer	0.000172	0.00309	CcSEcCtD
Cidofovir—Amnesia—Capecitabine—esophageal cancer	0.000169	0.00303	CcSEcCtD
Cidofovir—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.000168	0.00302	CcSEcCtD
Cidofovir—Thirst—Capecitabine—esophageal cancer	0.000167	0.00299	CcSEcCtD
Cidofovir—TYMP—Fluoropyrimidine Activity—SMUG1—esophageal cancer	0.000166	0.0865	CbGpPWpGaD
Cidofovir—Renal failure—Cisplatin—esophageal cancer	0.000163	0.00293	CcSEcCtD
Cidofovir—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000163	0.00292	CcSEcCtD
Cidofovir—Stomatitis—Cisplatin—esophageal cancer	0.000162	0.0029	CcSEcCtD
Cidofovir—Conjunctivitis—Cisplatin—esophageal cancer	0.000161	0.0029	CcSEcCtD
Cidofovir—Hyponatraemia—Capecitabine—esophageal cancer	0.000159	0.00286	CcSEcCtD
Cidofovir—Melaena—Methotrexate—esophageal cancer	0.000159	0.00285	CcSEcCtD
Cidofovir—Diplopia—Capecitabine—esophageal cancer	0.000159	0.00285	CcSEcCtD
Cidofovir—Osteoarthritis—Capecitabine—esophageal cancer	0.000159	0.00285	CcSEcCtD
Cidofovir—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000159	0.00285	CcSEcCtD
Cidofovir—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000157	0.00283	CcSEcCtD
Cidofovir—Migraine—Capecitabine—esophageal cancer	0.000156	0.00281	CcSEcCtD
Cidofovir—Face oedema—Capecitabine—esophageal cancer	0.000153	0.00275	CcSEcCtD
Cidofovir—Aplastic anaemia—Methotrexate—esophageal cancer	0.000153	0.00274	CcSEcCtD
Cidofovir—Urinary retention—Capecitabine—esophageal cancer	0.000151	0.00271	CcSEcCtD
Cidofovir—Ataxia—Capecitabine—esophageal cancer	0.000149	0.00268	CcSEcCtD
Cidofovir—Blood creatinine increased—Capecitabine—esophageal cancer	0.000149	0.00267	CcSEcCtD
Cidofovir—Dehydration—Capecitabine—esophageal cancer	0.000148	0.00265	CcSEcCtD
Cidofovir—Urine output increased—Methotrexate—esophageal cancer	0.000147	0.00264	CcSEcCtD
Cidofovir—Mouth ulceration—Methotrexate—esophageal cancer	0.000147	0.00264	CcSEcCtD
Cidofovir—Urinary tract disorder—Cisplatin—esophageal cancer	0.000147	0.00264	CcSEcCtD
Cidofovir—Urethral disorder—Cisplatin—esophageal cancer	0.000146	0.00262	CcSEcCtD
Cidofovir—Dry skin—Capecitabine—esophageal cancer	0.000145	0.00261	CcSEcCtD
Cidofovir—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000145	0.0026	CcSEcCtD
Cidofovir—Hypokalaemia—Capecitabine—esophageal cancer	0.000144	0.00259	CcSEcCtD
Cidofovir—Visual impairment—Cisplatin—esophageal cancer	0.000144	0.00258	CcSEcCtD
Cidofovir—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000143	0.00257	CcSEcCtD
Cidofovir—Sepsis—Methotrexate—esophageal cancer	0.000141	0.00254	CcSEcCtD
Cidofovir—Gastritis—Capecitabine—esophageal cancer	0.00014	0.00252	CcSEcCtD
Cidofovir—Muscular weakness—Capecitabine—esophageal cancer	0.00014	0.00251	CcSEcCtD
Cidofovir—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00014	0.00251	CcSEcCtD
Cidofovir—Eye disorder—Cisplatin—esophageal cancer	0.000139	0.0025	CcSEcCtD
Cidofovir—Tinnitus—Cisplatin—esophageal cancer	0.000139	0.00249	CcSEcCtD
Cidofovir—Lymphadenopathy—Methotrexate—esophageal cancer	0.000138	0.00249	CcSEcCtD
Cidofovir—Flushing—Cisplatin—esophageal cancer	0.000138	0.00248	CcSEcCtD
Cidofovir—Asthma—Capecitabine—esophageal cancer	0.000137	0.00246	CcSEcCtD
Cidofovir—Dysphagia—Capecitabine—esophageal cancer	0.000137	0.00246	CcSEcCtD
Cidofovir—Polyuria—Methotrexate—esophageal cancer	0.000135	0.00242	CcSEcCtD
Cidofovir—Mediastinal disorder—Cisplatin—esophageal cancer	0.000134	0.00241	CcSEcCtD
Cidofovir—Bronchitis—Capecitabine—esophageal cancer	0.000132	0.00237	CcSEcCtD
Cidofovir—Alopecia—Cisplatin—esophageal cancer	0.000132	0.00236	CcSEcCtD
Cidofovir—Pancytopenia—Capecitabine—esophageal cancer	0.00013	0.00234	CcSEcCtD
Cidofovir—Neutropenia—Capecitabine—esophageal cancer	0.000128	0.0023	CcSEcCtD
Cidofovir—Dysuria—Capecitabine—esophageal cancer	0.000128	0.0023	CcSEcCtD
Cidofovir—Renal failure acute—Methotrexate—esophageal cancer	0.000128	0.0023	CcSEcCtD
Cidofovir—Flatulence—Cisplatin—esophageal cancer	0.000128	0.00229	CcSEcCtD
Cidofovir—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000125	0.00225	CcSEcCtD
Cidofovir—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000125	0.00225	CcSEcCtD
Cidofovir—Weight increased—Capecitabine—esophageal cancer	0.000125	0.00224	CcSEcCtD
Cidofovir—Muscle spasms—Cisplatin—esophageal cancer	0.000125	0.00224	CcSEcCtD
Cidofovir—Weight decreased—Capecitabine—esophageal cancer	0.000124	0.00223	CcSEcCtD
Cidofovir—Hyperglycaemia—Capecitabine—esophageal cancer	0.000124	0.00222	CcSEcCtD
Cidofovir—Pneumonia—Capecitabine—esophageal cancer	0.000123	0.00221	CcSEcCtD
Cidofovir—Tremor—Cisplatin—esophageal cancer	0.000121	0.00218	CcSEcCtD
Cidofovir—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000121	0.00218	CcSEcCtD
Cidofovir—Ill-defined disorder—Cisplatin—esophageal cancer	0.00012	0.00216	CcSEcCtD
Cidofovir—Renal failure—Capecitabine—esophageal cancer	0.00012	0.00216	CcSEcCtD
Cidofovir—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00012	0.00215	CcSEcCtD
Cidofovir—Anaemia—Cisplatin—esophageal cancer	0.00012	0.00215	CcSEcCtD
Cidofovir—Stomatitis—Capecitabine—esophageal cancer	0.000119	0.00214	CcSEcCtD
Cidofovir—Jaundice—Capecitabine—esophageal cancer	0.000119	0.00214	CcSEcCtD
Cidofovir—Conjunctivitis—Capecitabine—esophageal cancer	0.000119	0.00213	CcSEcCtD
Cidofovir—Urinary tract infection—Capecitabine—esophageal cancer	0.000119	0.00213	CcSEcCtD
Cidofovir—Osteoarthritis—Methotrexate—esophageal cancer	0.000118	0.00212	CcSEcCtD
Cidofovir—Malaise—Cisplatin—esophageal cancer	0.000117	0.0021	CcSEcCtD
Cidofovir—Haematuria—Capecitabine—esophageal cancer	0.000117	0.00209	CcSEcCtD
Cidofovir—Leukopenia—Cisplatin—esophageal cancer	0.000116	0.00208	CcSEcCtD
Cidofovir—Epistaxis—Capecitabine—esophageal cancer	0.000115	0.00207	CcSEcCtD
Cidofovir—Convulsion—Cisplatin—esophageal cancer	0.000112	0.00202	CcSEcCtD
Cidofovir—Ataxia—Methotrexate—esophageal cancer	0.000111	0.00199	CcSEcCtD
Cidofovir—Myalgia—Cisplatin—esophageal cancer	0.00011	0.00198	CcSEcCtD
Cidofovir—Rhinitis—Capecitabine—esophageal cancer	0.00011	0.00198	CcSEcCtD
Cidofovir—Anxiety—Cisplatin—esophageal cancer	0.00011	0.00198	CcSEcCtD
Cidofovir—Hepatitis—Capecitabine—esophageal cancer	0.00011	0.00197	CcSEcCtD
Cidofovir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00011	0.00197	CcSEcCtD
Cidofovir—Discomfort—Cisplatin—esophageal cancer	0.000109	0.00196	CcSEcCtD
Cidofovir—Pharyngitis—Capecitabine—esophageal cancer	0.000109	0.00196	CcSEcCtD
Cidofovir—Urinary tract disorder—Capecitabine—esophageal cancer	0.000108	0.00195	CcSEcCtD
Cidofovir—Oedema peripheral—Capecitabine—esophageal cancer	0.000108	0.00194	CcSEcCtD
Cidofovir—Urethral disorder—Capecitabine—esophageal cancer	0.000108	0.00193	CcSEcCtD
Cidofovir—Oedema—Cisplatin—esophageal cancer	0.000106	0.0019	CcSEcCtD
Cidofovir—Anaphylactic shock—Cisplatin—esophageal cancer	0.000106	0.0019	CcSEcCtD
Cidofovir—Visual impairment—Capecitabine—esophageal cancer	0.000106	0.0019	CcSEcCtD
Cidofovir—Infection—Cisplatin—esophageal cancer	0.000105	0.00189	CcSEcCtD
Cidofovir—Erythema multiforme—Capecitabine—esophageal cancer	0.000104	0.00186	CcSEcCtD
Cidofovir—Nervous system disorder—Cisplatin—esophageal cancer	0.000104	0.00186	CcSEcCtD
Cidofovir—Thrombocytopenia—Cisplatin—esophageal cancer	0.000104	0.00186	CcSEcCtD
Cidofovir—Tachycardia—Cisplatin—esophageal cancer	0.000103	0.00185	CcSEcCtD
Cidofovir—Skin disorder—Cisplatin—esophageal cancer	0.000103	0.00185	CcSEcCtD
Cidofovir—Eye disorder—Capecitabine—esophageal cancer	0.000103	0.00184	CcSEcCtD
Cidofovir—Tinnitus—Capecitabine—esophageal cancer	0.000102	0.00184	CcSEcCtD
Cidofovir—Hyperhidrosis—Cisplatin—esophageal cancer	0.000102	0.00184	CcSEcCtD
Cidofovir—Asthma—Methotrexate—esophageal cancer	0.000102	0.00183	CcSEcCtD
Cidofovir—Flushing—Capecitabine—esophageal cancer	0.000102	0.00183	CcSEcCtD
Cidofovir—Anorexia—Cisplatin—esophageal cancer	0.000101	0.00181	CcSEcCtD
Cidofovir—Pancreatitis—Methotrexate—esophageal cancer	0.0001	0.0018	CcSEcCtD
Cidofovir—Angiopathy—Capecitabine—esophageal cancer	9.96e-05	0.00179	CcSEcCtD
Cidofovir—Mediastinal disorder—Capecitabine—esophageal cancer	9.89e-05	0.00178	CcSEcCtD
Cidofovir—Hypotension—Cisplatin—esophageal cancer	9.89e-05	0.00178	CcSEcCtD
Cidofovir—Chills—Capecitabine—esophageal cancer	9.85e-05	0.00177	CcSEcCtD
Cidofovir—Alopecia—Capecitabine—esophageal cancer	9.7e-05	0.00174	CcSEcCtD
Cidofovir—Pancytopenia—Methotrexate—esophageal cancer	9.7e-05	0.00174	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Cisplatin—esophageal cancer	9.64e-05	0.00173	CcSEcCtD
Cidofovir—Dysuria—Methotrexate—esophageal cancer	9.55e-05	0.00171	CcSEcCtD
Cidofovir—Neutropenia—Methotrexate—esophageal cancer	9.55e-05	0.00171	CcSEcCtD
Cidofovir—Paraesthesia—Cisplatin—esophageal cancer	9.5e-05	0.00171	CcSEcCtD
Cidofovir—TYMP—Bladder Cancer—RB1—esophageal cancer	9.47e-05	0.0494	CbGpPWpGaD
Cidofovir—Dyspnoea—Cisplatin—esophageal cancer	9.43e-05	0.00169	CcSEcCtD
Cidofovir—Flatulence—Capecitabine—esophageal cancer	9.42e-05	0.00169	CcSEcCtD
Cidofovir—Dysgeusia—Capecitabine—esophageal cancer	9.36e-05	0.00168	CcSEcCtD
Cidofovir—Photosensitivity reaction—Methotrexate—esophageal cancer	9.32e-05	0.00167	CcSEcCtD
Cidofovir—Back pain—Capecitabine—esophageal cancer	9.24e-05	0.00166	CcSEcCtD
Cidofovir—Decreased appetite—Cisplatin—esophageal cancer	9.2e-05	0.00165	CcSEcCtD
Cidofovir—Muscle spasms—Capecitabine—esophageal cancer	9.19e-05	0.00165	CcSEcCtD
Cidofovir—Pneumonia—Methotrexate—esophageal cancer	9.16e-05	0.00164	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Cisplatin—esophageal cancer	9.14e-05	0.00164	CcSEcCtD
Cidofovir—Pain—Cisplatin—esophageal cancer	9.05e-05	0.00162	CcSEcCtD
Cidofovir—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	9.03e-05	0.00162	CcSEcCtD
Cidofovir—Tremor—Capecitabine—esophageal cancer	8.95e-05	0.00161	CcSEcCtD
Cidofovir—Renal failure—Methotrexate—esophageal cancer	8.95e-05	0.00161	CcSEcCtD
Cidofovir—Stomatitis—Methotrexate—esophageal cancer	8.87e-05	0.00159	CcSEcCtD
Cidofovir—Ill-defined disorder—Capecitabine—esophageal cancer	8.87e-05	0.00159	CcSEcCtD
Cidofovir—Conjunctivitis—Methotrexate—esophageal cancer	8.85e-05	0.00159	CcSEcCtD
Cidofovir—Anaemia—Capecitabine—esophageal cancer	8.83e-05	0.00159	CcSEcCtD
Cidofovir—Sweating—Methotrexate—esophageal cancer	8.73e-05	0.00157	CcSEcCtD
Cidofovir—Feeling abnormal—Cisplatin—esophageal cancer	8.72e-05	0.00157	CcSEcCtD
Cidofovir—Haematuria—Methotrexate—esophageal cancer	8.68e-05	0.00156	CcSEcCtD
Cidofovir—Malaise—Capecitabine—esophageal cancer	8.62e-05	0.00155	CcSEcCtD
Cidofovir—Epistaxis—Methotrexate—esophageal cancer	8.59e-05	0.00154	CcSEcCtD
Cidofovir—Vertigo—Capecitabine—esophageal cancer	8.59e-05	0.00154	CcSEcCtD
Cidofovir—Syncope—Capecitabine—esophageal cancer	8.57e-05	0.00154	CcSEcCtD
Cidofovir—Leukopenia—Capecitabine—esophageal cancer	8.55e-05	0.00154	CcSEcCtD
Cidofovir—Loss of consciousness—Capecitabine—esophageal cancer	8.4e-05	0.00151	CcSEcCtD
Cidofovir—Body temperature increased—Cisplatin—esophageal cancer	8.36e-05	0.0015	CcSEcCtD
Cidofovir—Cough—Capecitabine—esophageal cancer	8.34e-05	0.0015	CcSEcCtD
Cidofovir—TYMP—Bladder Cancer—CDKN2A—esophageal cancer	8.32e-05	0.0434	CbGpPWpGaD
Cidofovir—Hypertension—Capecitabine—esophageal cancer	8.25e-05	0.00148	CcSEcCtD
Cidofovir—Hepatitis—Methotrexate—esophageal cancer	8.17e-05	0.00147	CcSEcCtD
Cidofovir—Arthralgia—Capecitabine—esophageal cancer	8.14e-05	0.00146	CcSEcCtD
Cidofovir—Myalgia—Capecitabine—esophageal cancer	8.14e-05	0.00146	CcSEcCtD
Cidofovir—Chest pain—Capecitabine—esophageal cancer	8.14e-05	0.00146	CcSEcCtD
Cidofovir—Pharyngitis—Methotrexate—esophageal cancer	8.11e-05	0.00146	CcSEcCtD
Cidofovir—Anxiety—Capecitabine—esophageal cancer	8.11e-05	0.00146	CcSEcCtD
Cidofovir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	8.08e-05	0.00145	CcSEcCtD
Cidofovir—Urinary tract disorder—Methotrexate—esophageal cancer	8.07e-05	0.00145	CcSEcCtD
Cidofovir—Discomfort—Capecitabine—esophageal cancer	8.04e-05	0.00144	CcSEcCtD
Cidofovir—Urethral disorder—Methotrexate—esophageal cancer	8.01e-05	0.00144	CcSEcCtD
Cidofovir—TYMP—Bladder Cancer—ERBB2—esophageal cancer	7.96e-05	0.0415	CbGpPWpGaD
Cidofovir—Dry mouth—Capecitabine—esophageal cancer	7.96e-05	0.00143	CcSEcCtD
Cidofovir—Visual impairment—Methotrexate—esophageal cancer	7.88e-05	0.00141	CcSEcCtD
Cidofovir—Confusional state—Capecitabine—esophageal cancer	7.86e-05	0.00141	CcSEcCtD
Cidofovir—Oedema—Capecitabine—esophageal cancer	7.8e-05	0.0014	CcSEcCtD
Cidofovir—Hypersensitivity—Cisplatin—esophageal cancer	7.8e-05	0.0014	CcSEcCtD
Cidofovir—Infection—Capecitabine—esophageal cancer	7.75e-05	0.00139	CcSEcCtD
Cidofovir—Erythema multiforme—Methotrexate—esophageal cancer	7.73e-05	0.00139	CcSEcCtD
Cidofovir—Shock—Capecitabine—esophageal cancer	7.67e-05	0.00138	CcSEcCtD
Cidofovir—Nervous system disorder—Capecitabine—esophageal cancer	7.65e-05	0.00137	CcSEcCtD
Cidofovir—Eye disorder—Methotrexate—esophageal cancer	7.64e-05	0.00137	CcSEcCtD
Cidofovir—Thrombocytopenia—Capecitabine—esophageal cancer	7.64e-05	0.00137	CcSEcCtD
Cidofovir—Tinnitus—Methotrexate—esophageal cancer	7.62e-05	0.00137	CcSEcCtD
Cidofovir—Tachycardia—Capecitabine—esophageal cancer	7.61e-05	0.00137	CcSEcCtD
Cidofovir—Asthenia—Cisplatin—esophageal cancer	7.59e-05	0.00136	CcSEcCtD
Cidofovir—Skin disorder—Capecitabine—esophageal cancer	7.58e-05	0.00136	CcSEcCtD
Cidofovir—Hyperhidrosis—Capecitabine—esophageal cancer	7.54e-05	0.00135	CcSEcCtD
Cidofovir—Anorexia—Capecitabine—esophageal cancer	7.43e-05	0.00134	CcSEcCtD
Cidofovir—Angiopathy—Methotrexate—esophageal cancer	7.41e-05	0.00133	CcSEcCtD
Cidofovir—Mediastinal disorder—Methotrexate—esophageal cancer	7.37e-05	0.00132	CcSEcCtD
Cidofovir—Chills—Methotrexate—esophageal cancer	7.33e-05	0.00132	CcSEcCtD
Cidofovir—Hypotension—Capecitabine—esophageal cancer	7.29e-05	0.00131	CcSEcCtD
Cidofovir—Diarrhoea—Cisplatin—esophageal cancer	7.24e-05	0.0013	CcSEcCtD
Cidofovir—Alopecia—Methotrexate—esophageal cancer	7.22e-05	0.0013	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Capecitabine—esophageal cancer	7.11e-05	0.00128	CcSEcCtD
Cidofovir—Insomnia—Capecitabine—esophageal cancer	7.05e-05	0.00127	CcSEcCtD
Cidofovir—TYMP—Bladder Cancer—CCND1—esophageal cancer	7.03e-05	0.0367	CbGpPWpGaD
Cidofovir—Paraesthesia—Capecitabine—esophageal cancer	7e-05	0.00126	CcSEcCtD
Cidofovir—Dysgeusia—Methotrexate—esophageal cancer	6.97e-05	0.00125	CcSEcCtD
Cidofovir—Dyspnoea—Capecitabine—esophageal cancer	6.95e-05	0.00125	CcSEcCtD
Cidofovir—Back pain—Methotrexate—esophageal cancer	6.88e-05	0.00124	CcSEcCtD
Cidofovir—Dyspepsia—Capecitabine—esophageal cancer	6.87e-05	0.00123	CcSEcCtD
Cidofovir—TYMP—Bladder Cancer—CDKN1A—esophageal cancer	6.8e-05	0.0355	CbGpPWpGaD
Cidofovir—Decreased appetite—Capecitabine—esophageal cancer	6.78e-05	0.00122	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Capecitabine—esophageal cancer	6.73e-05	0.00121	CcSEcCtD
Cidofovir—Vomiting—Cisplatin—esophageal cancer	6.73e-05	0.00121	CcSEcCtD
Cidofovir—Rash—Cisplatin—esophageal cancer	6.67e-05	0.0012	CcSEcCtD
Cidofovir—Pain—Capecitabine—esophageal cancer	6.67e-05	0.0012	CcSEcCtD
Cidofovir—Constipation—Capecitabine—esophageal cancer	6.67e-05	0.0012	CcSEcCtD
Cidofovir—Dermatitis—Cisplatin—esophageal cancer	6.67e-05	0.0012	CcSEcCtD
Cidofovir—Ill-defined disorder—Methotrexate—esophageal cancer	6.6e-05	0.00119	CcSEcCtD
Cidofovir—Anaemia—Methotrexate—esophageal cancer	6.58e-05	0.00118	CcSEcCtD
Cidofovir—Feeling abnormal—Capecitabine—esophageal cancer	6.43e-05	0.00115	CcSEcCtD
Cidofovir—Malaise—Methotrexate—esophageal cancer	6.42e-05	0.00115	CcSEcCtD
Cidofovir—Vertigo—Methotrexate—esophageal cancer	6.39e-05	0.00115	CcSEcCtD
Cidofovir—Gastrointestinal pain—Capecitabine—esophageal cancer	6.38e-05	0.00115	CcSEcCtD
Cidofovir—Leukopenia—Methotrexate—esophageal cancer	6.37e-05	0.00114	CcSEcCtD
Cidofovir—Nausea—Cisplatin—esophageal cancer	6.29e-05	0.00113	CcSEcCtD
Cidofovir—Cough—Methotrexate—esophageal cancer	6.21e-05	0.00111	CcSEcCtD
Cidofovir—Urticaria—Capecitabine—esophageal cancer	6.2e-05	0.00111	CcSEcCtD
Cidofovir—Body temperature increased—Capecitabine—esophageal cancer	6.17e-05	0.00111	CcSEcCtD
Cidofovir—Abdominal pain—Capecitabine—esophageal cancer	6.17e-05	0.00111	CcSEcCtD
Cidofovir—Convulsion—Methotrexate—esophageal cancer	6.16e-05	0.00111	CcSEcCtD
Cidofovir—Myalgia—Methotrexate—esophageal cancer	6.06e-05	0.00109	CcSEcCtD
Cidofovir—Arthralgia—Methotrexate—esophageal cancer	6.06e-05	0.00109	CcSEcCtD
Cidofovir—Chest pain—Methotrexate—esophageal cancer	6.06e-05	0.00109	CcSEcCtD
Cidofovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	6.02e-05	0.00108	CcSEcCtD
Cidofovir—Discomfort—Methotrexate—esophageal cancer	5.98e-05	0.00107	CcSEcCtD
Cidofovir—Confusional state—Methotrexate—esophageal cancer	5.85e-05	0.00105	CcSEcCtD
Cidofovir—Anaphylactic shock—Methotrexate—esophageal cancer	5.81e-05	0.00104	CcSEcCtD
Cidofovir—Infection—Methotrexate—esophageal cancer	5.77e-05	0.00104	CcSEcCtD
Cidofovir—Hypersensitivity—Capecitabine—esophageal cancer	5.75e-05	0.00103	CcSEcCtD
Cidofovir—Nervous system disorder—Methotrexate—esophageal cancer	5.69e-05	0.00102	CcSEcCtD
Cidofovir—Thrombocytopenia—Methotrexate—esophageal cancer	5.69e-05	0.00102	CcSEcCtD
Cidofovir—TYMP—Bladder Cancer—MYC—esophageal cancer	5.64e-05	0.0294	CbGpPWpGaD
Cidofovir—Skin disorder—Methotrexate—esophageal cancer	5.64e-05	0.00101	CcSEcCtD
Cidofovir—Hyperhidrosis—Methotrexate—esophageal cancer	5.61e-05	0.00101	CcSEcCtD
Cidofovir—Asthenia—Capecitabine—esophageal cancer	5.6e-05	0.00101	CcSEcCtD
Cidofovir—Anorexia—Methotrexate—esophageal cancer	5.53e-05	0.000994	CcSEcCtD
Cidofovir—Pruritus—Capecitabine—esophageal cancer	5.52e-05	0.000991	CcSEcCtD
Cidofovir—TYMP—Bladder Cancer—EGFR—esophageal cancer	5.52e-05	0.0288	CbGpPWpGaD
Cidofovir—Hypotension—Methotrexate—esophageal cancer	5.43e-05	0.000974	CcSEcCtD
Cidofovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	5.38e-05	0.0281	CbGpPWpGaD
Cidofovir—Diarrhoea—Capecitabine—esophageal cancer	5.34e-05	0.000958	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Methotrexate—esophageal cancer	5.29e-05	0.00095	CcSEcCtD
Cidofovir—Insomnia—Methotrexate—esophageal cancer	5.25e-05	0.000943	CcSEcCtD
Cidofovir—Paraesthesia—Methotrexate—esophageal cancer	5.21e-05	0.000936	CcSEcCtD
Cidofovir—Dyspnoea—Methotrexate—esophageal cancer	5.18e-05	0.00093	CcSEcCtD
Cidofovir—Somnolence—Methotrexate—esophageal cancer	5.16e-05	0.000927	CcSEcCtD
Cidofovir—Dizziness—Capecitabine—esophageal cancer	5.16e-05	0.000926	CcSEcCtD
Cidofovir—Dyspepsia—Methotrexate—esophageal cancer	5.11e-05	0.000918	CcSEcCtD
Cidofovir—Decreased appetite—Methotrexate—esophageal cancer	5.05e-05	0.000906	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Methotrexate—esophageal cancer	5.01e-05	0.0009	CcSEcCtD
Cidofovir—Pain—Methotrexate—esophageal cancer	4.97e-05	0.000892	CcSEcCtD
Cidofovir—Vomiting—Capecitabine—esophageal cancer	4.96e-05	0.000891	CcSEcCtD
Cidofovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	4.92e-05	0.0257	CbGpPWpGaD
Cidofovir—Rash—Capecitabine—esophageal cancer	4.92e-05	0.000883	CcSEcCtD
Cidofovir—Dermatitis—Capecitabine—esophageal cancer	4.91e-05	0.000882	CcSEcCtD
Cidofovir—Headache—Capecitabine—esophageal cancer	4.89e-05	0.000878	CcSEcCtD
Cidofovir—Feeling abnormal—Methotrexate—esophageal cancer	4.78e-05	0.000859	CcSEcCtD
Cidofovir—Gastrointestinal pain—Methotrexate—esophageal cancer	4.75e-05	0.000853	CcSEcCtD
Cidofovir—Nausea—Capecitabine—esophageal cancer	4.63e-05	0.000832	CcSEcCtD
Cidofovir—TYMP—Bladder Cancer—TP53—esophageal cancer	4.63e-05	0.0242	CbGpPWpGaD
Cidofovir—Urticaria—Methotrexate—esophageal cancer	4.61e-05	0.000828	CcSEcCtD
Cidofovir—Abdominal pain—Methotrexate—esophageal cancer	4.59e-05	0.000824	CcSEcCtD
Cidofovir—Body temperature increased—Methotrexate—esophageal cancer	4.59e-05	0.000824	CcSEcCtD
Cidofovir—TYMP—Fluoropyrimidine Activity—TP53—esophageal cancer	4.41e-05	0.023	CbGpPWpGaD
Cidofovir—Hypersensitivity—Methotrexate—esophageal cancer	4.28e-05	0.000768	CcSEcCtD
Cidofovir—Asthenia—Methotrexate—esophageal cancer	4.17e-05	0.000748	CcSEcCtD
Cidofovir—Pruritus—Methotrexate—esophageal cancer	4.11e-05	0.000738	CcSEcCtD
Cidofovir—Diarrhoea—Methotrexate—esophageal cancer	3.97e-05	0.000713	CcSEcCtD
Cidofovir—Dizziness—Methotrexate—esophageal cancer	3.84e-05	0.00069	CcSEcCtD
Cidofovir—Vomiting—Methotrexate—esophageal cancer	3.69e-05	0.000663	CcSEcCtD
Cidofovir—Rash—Methotrexate—esophageal cancer	3.66e-05	0.000657	CcSEcCtD
Cidofovir—Dermatitis—Methotrexate—esophageal cancer	3.66e-05	0.000657	CcSEcCtD
Cidofovir—Headache—Methotrexate—esophageal cancer	3.64e-05	0.000653	CcSEcCtD
Cidofovir—Nausea—Methotrexate—esophageal cancer	3.45e-05	0.000619	CcSEcCtD
Cidofovir—SLC22A6—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	2.44e-05	0.0127	CbGpPWpGaD
Cidofovir—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	2.24e-05	0.0117	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—SLC52A3—esophageal cancer	2.22e-05	0.0116	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—BLVRB—esophageal cancer	2.22e-05	0.0116	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—CA1—esophageal cancer	1.88e-05	0.00982	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—SLC10A2—esophageal cancer	1.88e-05	0.00982	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—CA2—esophageal cancer	1.72e-05	0.00898	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—PLCE1—esophageal cancer	1.6e-05	0.00835	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—ADH7—esophageal cancer	1.6e-05	0.00835	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—ADH1B—esophageal cancer	1.4e-05	0.00732	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	1.39e-05	0.00727	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	1.31e-05	0.00683	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—CYP26A1—esophageal cancer	1.31e-05	0.00681	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—ALOX15—esophageal cancer	1.27e-05	0.00664	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	1.24e-05	0.00648	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—TPI1—esophageal cancer	1.21e-05	0.00633	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—GSTO1—esophageal cancer	1.21e-05	0.00633	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—AQP3—esophageal cancer	1.19e-05	0.00618	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—ALDOB—esophageal cancer	1.16e-05	0.00607	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—ATP4A—esophageal cancer	1.14e-05	0.00593	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	1.14e-05	0.00593	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—GAPDH—esophageal cancer	1.12e-05	0.00584	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—CRABP1—esophageal cancer	1.11e-05	0.00579	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—GNG7—esophageal cancer	1.06e-05	0.00551	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—ALDH2—esophageal cancer	9.9e-06	0.00516	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—GSTT1—esophageal cancer	9.41e-06	0.00491	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—CYP2A6—esophageal cancer	9.3e-06	0.00485	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—PTGS1—esophageal cancer	8.82e-06	0.0046	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—ENO1—esophageal cancer	8.82e-06	0.0046	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—PSME2—esophageal cancer	8.69e-06	0.00453	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—PSME1—esophageal cancer	8.69e-06	0.00453	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—ABCC2—esophageal cancer	8.61e-06	0.00449	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—GNG7—esophageal cancer	7.81e-06	0.00407	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—CYP1B1—esophageal cancer	7.5e-06	0.00391	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—CYP19A1—esophageal cancer	7.05e-06	0.00368	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—HMOX1—esophageal cancer	6.43e-06	0.00336	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—ABCB1—esophageal cancer	6.18e-06	0.00322	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.76e-06	0.00248	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	4.57e-06	0.00238	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—CREBBP—esophageal cancer	4.13e-06	0.00215	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—NOS3—esophageal cancer	3.7e-06	0.00193	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—PTGS2—esophageal cancer	3.38e-06	0.00176	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.05e-06	0.00159	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—EP300—esophageal cancer	2.81e-06	0.00147	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—PIK3CA—esophageal cancer	2.08e-06	0.00108	CbGpPWpGaD
